Changes in post-vaccination immunity to whooping cough in children with chronic kidney disease stages 3 and 5
https://doi.org/10.46563/1560-9561-2025-28-6-456-461
EDN: mnhjlb
Abstract
Introduction. Staging of chronic kidney disease (CKD) is used in nephrology practice to assess the risk of kidney disease progression and determine the timing of renal replacement therapy (RRT). Infections, including vaccine-preventable ones, remain among the main causes of decreased overall and renal survival after kidney transplantation, necessitating monitoring of the complete implementation of preventive measures before initiating RRT. The aim: to determine the presence and persistence of post-vaccination immunity to whooping cough in children in the pre-transplant period at stages 3 and 5 of CKD.
Materials and methods. A retrospective analysis of the medical records of 91 patient was conducted: 42 children with CKD stage 3 (group 1) and 49 children with CKD stage 5 (group 2), aged 7 to 17 years, with an assessment of the presence of protective IgG levels to the pertussis pathogen Bordetella pertussis (BP) after previous vaccination. The comparison group consisted of 25 children without chronic diseases.
Results. The average frequency of positive IgG levels in children in group 1 with stage 3 CKD was found to m be only 33.3%, while in children with CKD stage 5 it was 52.8%. Positive IgG levels to BP in both groups were higher in children with non-immune-mediated pathology (Alport syndrome, congenital renal malformations, polycystic disease, etc.) compared to patients with primary steroid-resistant nephrotic syndrome. Positive levels of specific antibodies were detected in children in both groups in the period after vaccination up to 5 years of age — in 57.2% of children in group 1 and 55.1% in group 2.
Conclusion. Analysis of our sample shows about half of the patients (67.7% of patients with stage 3 CKD and 47% of children with stage 5 CKD) to have negative IgG to BP, which significantly increases the risk of infection in this cohort of patients and requires mandatory immunization in the pre-transplant period.
Contribution:
Matsneva I.Yu., Komarova O.V. — concept;
Matsneva I.Yu. Konyashin M.V., Kushtysev E.A., Dergacheva Yu.S. — collection and processing of material;
Matsneva I.Yu. — writing the text;
Trofimova A.G., Kurbatova O.V., Tsygin A.N. — editing the text.
All co-authors — approval of the final version of the article, responsibility for the integrity of all parts of the article.
Acknowledgment. The study had no sponsorship.
Conflict of interest. The authors declare no conflict of interest.
Received: October 28, 2025
Accepted: November 27, 2025
Published: December 25, 2025
About the Authors
Inna Yu. MatsnevaRussian Federation
Graduate student, pediatrician at the Emergency department, National Medical Research Center for Children’s Health
e-mail: inna.matsneva19@gmail.com
Olga V. Komarova
Russian Federation
Arina G. Trofimova
Russian Federation
Olga V. Kurbatova
Russian Federation
Matvey V. Konyashin
Russian Federation
Evgeny A. Kushtysev
Russian Federation
Yulia S. Dergacheva
Russian Federation
Alexey N. Tsygin
Russian Federation
References
1. VanSickle J.S., Warady B.A. Chronic kidney disease in children. Pediatr. Clin. North Am. 2022: 69(6): 1239–54. https://doi.org/10.1016/j.pcl.2022.07.010
2. Levin A., Stevens P.E. Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014: 85(1): 49–61. https://doi.org/10.1038/ki.2013.444
3. Komarova O.V., Tsygin A.N., Fisenko A.P. Mechanisms of Progression of Chronic Kidney Disease in Children [Mekhanizmy progressirovaniya khronicheskoy bolezni pochek u detey: monografiya]. Moscow; 2019. (in Russian)
4. Kidney Disease Improving Global Outcomes (KDIGO) Working Group. KDIGO 2024 clinical practice guidelines for the evaluation and management of chronic kidney disease. Kidney Int. 2024; 105(4S): S117–314. https://doi.org/10.1016/j.kint.2023.10.018 (in Russian)
5. Bayko S.V. Chronic kidney disease in children: definition, classification, and diagnostics. Nefrologiya i dializ. 2020; 22(1): 53–70. https://doi.org/10.28996/2618-9801-2020-1-53-70 https://elibrary.ru/dvbbpa (in Russian)
6. Kulakova E.N., Nastausheva T.L., Zvyagina T.G., Skrylnikova M.A., Shlapakova L.N., Mokrousova A.Yu., et al. Problems of assessing glomerular filtration rate in adolescents and young adults: a descriptive review of the literature and case studies. Nefrologiya i dializ. 2021; 23(4): 472–88. https://doi.org/10.28996/2618-9801-2021-4-472-488 https://elibrary.ru/bcsxvv (in Russian)
7. Smirnov A.V., Shilov E.M., Dobronravov V.A., Kayukov I.G., Bobkova I.N., Shvetsov M.Yu., et al. National guidelines. Chronic kidney disease. Basic principles of screening, diagnosis, prevention, and approaches to treatment. Nefrologiya. 2012; 16(1): 89–115. https://elibrary.ru/njwage (in Russian)
8. Chebotareva N.V., Tsygin A.N., Bulanov N.M., Novikov P.I., Moiseev A.S., Maltseva V.V., et al. Terminal chronic renal failure that developed in childhood or adolescence. Klinicheskaya farmakologiya i terapiya. 2025; 34(1): 82–8. https://elibrary.ru/dxefek (in Russian)
9. Moiseev S.V., Chebotareva N.V., Bulanov N.M., Shilov E.M. Rare (orphan) hereditary diseases with kidney damage: approaches to diagnosis and treatment. Klinicheskaya farmakologiya i terapiya. 2023; 32(3): 6–18. https://elibrary.ru/ejbcpj (in Russian)
10. Reddy S., Chitturi C., Yee J. Vaccination in chronic kidney disease. Adv. Chronic Kidney Dis. 2019: 26(1): 72–8. https://doi.org/10.1053/j.ackd.2018.10.002
11. Kostinov M.P., Rusnak F.I. Vaccination of children with kidney diseases. Nefrologiya. 2016; 20(1): 24–35. https://elibrary.ru/wmwxyl (in Russian)
12. Kostinov M.P., Kharseeva G.G., Tyukavkina S.Yu., Vaccination of people with chronic pathology. Infektsionnye bolezni: Novosti. Mneniya. Obuchenie. 2021; 37(2): 99–107. https://doi.org/10.33029/2305-3496-2021-10-2-99-108 https://elibrary.ru/dgkjnj (in Russian)
13. Crichton H., Nkado N., Morrow B., Salie S., Procter C. Critical pertussis infection in the paediatric intensive care unit: A case series in an outbreak. South Afr. J. Crit. Care. 2025; 41(1): e2049. https://doi.org/10.7196/SAJCC.2025.v41i1.2049
14. Tatochenko V.K. Whooping cough – an undermanaged infection. Voprosy sovremennoy pediatrii. 2014; 13(2): 78–82. https://doi.org/10.15690/vsp.v13i2.975 https://elibrary.ru/sbualt (in Russian)
15. Subbotina K.A., Feldblyum I.V., Kochergina E.A., Lekhtina N.A. Epidemiological rationale for changing the strategy and tactics of specific whooping cough prevention in modern conditions. Epidemiologiya i vaktsinoprofilaktika. 2019; 18(2): 27–33. https://elibrary.ru/esxhnf (in Russian)
16. Fulton T.R., Phadke V.K., Orenstein W.A., Hinman A.R., Johnson W.D., Omer S.B. Protective effect of contemporary pertussis vaccines: a systematic review and meta-analysis. Clin. Infect. Dis. 2016; 62(9): 1100–10. https://doi.org/ 10.1093/cid/ciw051
17. Kostinov A.M., Kostinov M.P. Incidence of whooping cough and the effect of revaccination in preschool and school-age children. Infektsiya i immunitet. 2018; 8(3): 284–94. https://doi.org/10.15789/2220-7619-2018-3-284-294 https://elibrary.ru/ylkmvf (in Russian)
Review
For citations:
Matsneva I.Yu., Komarova O.V., Trofimova A.G., Kurbatova O.V., Konyashin M.V., Kushtysev E.A., Dergacheva Yu.S., Tsygin A.N. Changes in post-vaccination immunity to whooping cough in children with chronic kidney disease stages 3 and 5. M.Ya. Studenikin Russian Pediatric Journal. 2025;28(6):456-461. (In Russ.) https://doi.org/10.46563/1560-9561-2025-28-6-456-461. EDN: mnhjlb
JATS XML





















